A prospective, open, controlled and randomised study of clobazam versus carbamazepine in patients with frequent episodes of rolandic epilepsy;Estudio prospectivo, abierto, controlado y aleatorizado de clobazam frente a carbamacepina en pacientes con crisis frecuentes de epilepsia rolándica

Revista de Neurologia

Volumn 49, Issue 11, 2009, Pages 581-586

  Andrade Machado, René ^a   Garcia Espinosa A ^a   Machado Rojas, A ^a   Garcia Gonzalez M E ^a   Trapaga Quincoses O ^a   Morales Chacon L M ^a  

^a INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

Author keywords

Carbamazepine; Centrotemporal spikes; Clobazam; Randomised, controlled study; Rolandic epilepsy; Treatment

Indexed keywords

CARBAMAZEPINE; CLOBAZAM;

ACADEMIC ACHIEVEMENT; ADVERSE OUTCOME; ARTICLE; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM DISEASE; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVENING DOSAGE; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; IMMUNOTOXICITY; INFECTION; MALE; MONOTHERAPY; NEUROLOGIC DISEASE; PATIENT SATISFACTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY TRACT DISEASE; ROLANDIC EPILEPSY; SCHOOL CHILD; SEIZURE; SOMNOLENCE; TREATMENT OUTCOME; TREMOR; VERTIGO; VOMITING;

EID: 73949110692     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4911.2009525     Document Type: Article

References (22)

1. Wirrell E, Camfield CS, Camfield PR. Idiopathic and benign partial epilepsies of childhood. In Wyllie E, Gupta A, Lachhwani D, eds. The treatment of epilepsy. 4 ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 373-89.
2. Fejerman N. Benign childhood epilepsy with centrotemporal spikes. In Engel J Jr, Pedley TA, eds. Philadelphia: Lippincott Williams & Wilkins/Wolters Kluwer Business; 2008. p. 2369-77.
3. Andrade R, García-Espinosa A, De la Cruz-Turruelles A, Machado-Rojas A, Arteche-Prior M, Díaz-Pedraza A. Heminegligencia, trastorno cognitivo transitorio y actividad interictal en la epilepsia rolándica. Rev Neurol 2007; 44: 537-40
4. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 47: 1094-120.
5. Bourgeois BF. Drug treatment of benign focal epilepsies of childhood. Epilepsia 2000; 41: 1057-8.
6. Rating D, Wolf C, Bast T. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study: Sulthiame Study Group. Epilepsia 2000; 41: 1284-8.
7. Mitsudome A, Ohfu M, Yasumoto S, Ogawa A. The effectiveness of clonazepam on the rolandic discharges. Brain Dev 1997; 19: 274-8.
8. Chapman AG, Horton RW, Meldrum BS. Anticonvulsant action of a 1,5-benzodiazepine, clobazam, in reflex epilepsy. Epilepsia 1978; 19: 293-9.
9. Fielding S, Hoffmann I. Pharmacology of anti-anxiety drugs with special reference to clobazam. Br J Pharmacol 1979; 7: 7.
10. Gastaut H. Exceptional and unrecognized antiepileptic properties of a commercial anxiolytic: clobazam. Concours Med 1978; 100: 3697-701.
11. Gastaut H, Low MD. Antiepileptic properties of clobazam, a 1,5-benzodiazepine, in man. Epilepsia 1979; 20: 437-46.
12. Mehndiratta MM, Krishnamurthy M, Rajesh KN, Singh G. Clobazam monotherapy in drug naive adult patients with epilepsy. Seizure 2003; 12: 226-8.
13. Doi T, Ueda Y, Tokumaru J, Willmore LJ. Molecular regulation of glutamate and GABA transporter proteins by clobazam during epileptogenesis in Fe(+++)-induced epileptic rats. Brain Res Mol Brain Res 2005; 142: 91-6.
14. Allen JW, Oxley J, Robertson MM, Trimble MR, Richens A, Jawad SS. Clobazam as adjunctive treatment in refractory epilepsy. Br Med J (Clin Res Ed) 1993; 286: 1246-7.
15. Vajda FJ, Bladin PF, Parsons BJ. Clinical experience with clobazam: a new 1,5-benzodiazepine in the treatment of refractory epilepsy. Clin Exp Neurol 1985; 21: 177-82.
16. Munn R, Camfield P, Camfield C, Dooley J. Clobazam for refractory childhood seizure disorders - a valuable supplementary drug. Can J Neurol Sci 1998; 15: 406-8.
17. Munn R, Farrell K. Open study of clobazam in refractory epilepsy. Pediatr Neurol 1993; 9: 465-9.
18. Jan MM, Shaabat AO. Clobazam for the treatment of intractable childhood epilepsy. Saudi Med J 2000; 21: 622-4.
19. Sugai K. Clobazam as a new antiepileptic drug and clorazepate dipotassium as an alternative antiepileptic drug in Japan. Epilepsia 2004: 45 (Suppl 8): S20-5.
20. Silva RC, Montenegro MA, Guerreiro CA, Guerreiro MM. Clobazam as add-on therapy in children with epileptic encephalopathy. Can J Neurol Sci 2006, 33: 209-13.
21. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99.
22. Wechsler D. Wechsler Intelligence Scale for Children. London: Psychological Corporation; 1990.